Form 4: Encompass Health CEO Sells Shares for Tax Obligations

Encompass Health Corp's President and CEO, Mark J. Tarr, disposed of 2,488 shares of common stock to cover tax withholding obligations related to restricted stock vesting.

Summary

• Mark J. Tarr, President & CEO and Director of Encompass Health Corp (EHC), reported a transaction involving company common stock.
• On February 23, 2026, Mr. Tarr disposed of 2,488 shares of Encompass Health Common Stock.
• The shares were disposed of at a price of $106.15 per share.
• This transaction was identified as a withholding or surrender of shares to satisfy tax withholding obligations incurred due to the vesting of related restricted stock.
• Following this transaction, Mr. Tarr beneficially owns 443,149 shares of Encompass Health Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The disposition of shares is a non-discretionary transaction to cover tax obligations from restricted stock vesting, which is a routine occurrence for executives and does not indicate a change in company fundamentals or management's confidence.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to tax withholding upon restricted stock vesting, are common and routine events for executives in publicly traded companies across all industries. They typically do not reflect a change in management's sentiment towards the company's prospects but rather a standard compensation and tax planning mechanism.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in company fundamentals or management's outlook.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of shares by the CEO to cover tax obligations related to restricted stock vesting. Such transactions are common and do not typically reflect a change in the company's fundamental performance or the insider's long-term view. Therefore, a seasoned investor would likely maintain their current position, as this filing provides no new information to warrant a change in investment thesis.

Keywords

Encompass Health, EHC, Mark J. Tarr, Insider Transaction, Form 4, Stock Sale, CEO, Tax Withholding, Restricted Stock